Recently, several studies have reported an association between anxiety traits, affective disorders and autism and alleles of a functional promoter polymorphism (5HTT-LPR) in the human serotonin transporter (5HTT, SERT).
The serotonin (5HT) transporter (5HTT, SERT) is the major determinant of 5HT inactivation following release at synapses, 5, 6 is the site of action for many tricyclic antidepressants and the SSRIs (serotonin-selective reuptake inhibitor) 7, 8 and is also targeted by a number of psychostimulants including cocaine, methylphenidate, and MDMA 'ecstasy'. [9] [10] [11] Although no coding mutations 12, 13 have as yet been identified in the 5HTT gene that could explain reports of transport and binding deficits in affective disorders, [14] [15] [16] a functional polymorphism (5HTT-LPR) has been identified in the human 5HTT promoter. 1, 17 Two major alleles (termed 'short' (s) and 'long' (l)) correspond to the presence of 14 vs 16 20-23 bp repeat units upstream of the transcription start site. Recently, [18] [19] [20] additional low frequency alleles have been identified including a 20-repeat unit 'extra long allele' (el). Allelic status has been correlated with transcription efficiency and consequent transporter levels in heterologous models as well as native lymphocytes. 1, 17 To clarify the relationship between the 5HTT-LPR and potential transcriptional regulatory elements, we cloned the human 5HTT promoter from a P1-derived artificial chromosome (PAC) library. Our studies reveal the presence of 381 bp of unreported sequence between the polymorphic region and the transcription start site. The human genomic origin of this sequence was verified by Southern blot analysis of digested genomic samples, PCR reactions with flanking primers, and direct DNA sequencing. Here we report the sequence of the full 5HTT promoter including additional canonical transcription factor binding sites that may be critical for cell-specific or hormonally-regulated 5HTT expression. We also find evidence for instability within the 5HTT promoter that may account for the absence of this material in initial isolates.
Previously, 4 we isolated a PAC clone (No. 6324) encompassing the full human 5HTT gene. This clone contains the major transcription start site 4, 21 and the long allele of the 5HTT-LPR. Southern hybridization of restriction digests of the PAC clone using as a probe PCR-amplified 5HTT-LPR revealed anomalously large fragments ( Figure 1a) . Thus, based on the original report of the 5HTT promoter, a BamHI/HindIII digest of long allele PAC DNA hybridized with the 5HTT-LPR should identify a ෂ1.6-kb band whereas we found a band of ෂ2 kb. We tested the same digestion panel with human genomic DNA and found an identical migration pattern of hybridizing bands (Figure 1a) , suggesting that the anomalous migration pattern of PAC bands was not a result of the process of library creation or amplification. We could limit the origin of the unexpected DNA to within 500 bp of the 5HTT-LPR using an EcoRI/HindIII double digest (Figure 1b) . Figure 1 b also demonstrates the presence of additional material in the 5HTT promoter irrespective of 5HTT-LPR genotype as bands from s/s, s/l and l/l individuals migrated at larger than expected sizes.
To determine the physical basis for the larger than expected 5HTT promoter fragments, we subcloned and sequenced the 2-kb BamHI/HindIII fragment from the PAC clone. Results of this analysis are given in Figure  2 . We found an unreported 381-bp region (−1255 to −875 bp) upstream of the major transcription initiation site and immediately 3Ј of the 5HTT-LPR. BLAST searches of the GENBANK database did not identify sequence with sequences of any other known gene, supporting the contention that the new material did not arise from recombination with E. coli DNA during library propagation. This sequence contains a number Table 1 ), including Elk1, NfkB/Elk1, AP1, AP4 and SOX5 sites, that may play important roles in the endogenous expression of this gene and its sensitivity to allelic status at the 5HTT-LPR.
To extend our analysis of the prevalence of this addition to the 5HTT promoter, we designed a genomic PCR assay using oligonucleotide primers (RB 433 and RB 597) flanking the 5HTT-LPR and the novel sequence ( Figure 2a ). All 42 individuals genotyped in our assay displayed the novel sequence (data not shown). Amplifications reveal a single 1-kb band by ethidium staining as shown in Figure 3a . Sequence analysis of isolated PCR products revealed the same novel sequences as found in the PAC isolate. Interestingly, when we probed a blot of our PCR reactions with the 5HTT-LPR to verify band origin, for each individual we could detect a faint band migrating at the expected size (ෂ600 bp) for a promoter lacking the novel sequence (Figure 3b ). This smaller band does not appear to arise from the PCR reaction itself as PAC DNA amplified in parallel gives only the 1-kb band even though the amplification yields much more of the 1-kb product. Only a single 5HTT gene has been identified in the human genome 9, 21 and the smaller size of the faintly-amplified product suggests that it should have been amplified more efficiently were there a duplicate, unexpressed copy of the 5HTT gene in the genome. Lesch and coworkers 21 thus identified a form of the gene lacking what appears to be prevalent DNA sequences in the promoter. Conceivably, rearrangement at the 5HTT locus may have occurred during genomic library production or clone isolation and amplification. In our hands, the 5HTT promoter is difficult to amplify in E. coli and we often propagate rearranged templates. However, it is also possible that Lesch and colleagues preferentially subcloned genomic DNA that originally lacked these sequences. Since we can identMolecular Psychiatry ify material after genomic amplifications that matches the expected size of the Lesch promoter, a small, but detectible level of mosaicism at the 5HTT locus may exist, arising from in vivo instability of the 5HTT promoter. Mosaicism has, to our knowledge, not been associated with other neurotransmitter related genes, though this is quite common for trinucleotide repeat disorders. 22 It is thus possible that instability could be conferred in a cell or tissue-specific manner linked to the repetitive sequences in the polymorphic region. We cannot at this time rule out that such mosaicism might involve a loss of additional sequences in the 5HTT gene or their duplication elsewhere in the genome, though our Southern analyses verify only a single locus carrying the polymorphic region. That such instability would have functional consequences in the CNS appears likely as Mortensen and coworkers have also identified these novel sequences and found that they contribute to in vitro neuronal expression of the 5HTT promoter. 23 Alternatively, DNA extraction itself may precipitate deletions at this locus though the mechanism for such an excision is unclear. We are currently expanding our analyses to look for evidence of increased in vivo instability in the 5HTT promoter in disease states associated with altered serotonergic function. Regardless of whether 5HTT promoter instability exists at a sufficient level to compromise 5HTT transcription, transcription factors binding to the novel sequence should be considered as possible mediators of allelic influences on 5HTT transcription given their proximity to both the polymorphic sequences and the major transcription initiation site. Given the possibility that allelic status at the 5HTT-LPR may generate increased risk for affective disorders, substance abuse and autism, the full structure of the 5HTT promoter is essential for advanced studies in this area. Sites were selected for presentation due to 100% core sequence identity and total sequence identity for the motif of Ͼ85%. Notice the low level of product migrating with a size expected of templates lacking the novel sequence that is only seen with Southern analysis. Note also the differential migration pattern of the smaller bands, which vary with genotype as seen in the larger products, and the lack of smaller amplified products from PAC DNA, supporting the origin of the smaller products from endogenous 5HTT templates lacking the novel sequences.
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Methods
Analysis of the 5HTT promoter from PAC and genomic DNA
To identify elements linked to the 5HTT-LPR, the promoter of PAC clone 6324 (Genome Systems, St Louis, To validate the structure of the 5HTT promoter, genomic DNA was prepared from whole blood or fresh frozen brain tissue using the Puregene DNA Isolation Kit (Gentra Systems, Inc, Minneapolis, MN, USA). Restriction digests of DNAs, performed as described by the vendor (Promega, Madison, WI, USA; New England BioLabs, Beverly, MA, USA), were ethanol precipitated and electrophoresed in parallel with 1-kb DNA ladder (Gibco BRL, Gaithersburg, MD, USA) on a 0.5% 1 × TAE agarose gel containing 0.4 g ml −1 ethidium bromide. In some analyses, DNA ladder was radiolabeled with [
32 P]␣-dCTP using the Klenow fragment of T4 DNA polymerase following standard protocols. 25 After electrophoresis, DNA in the gel was depurinated and denatured by sequential 20-min incubations in 0.2 N HCl and 0.5 M NaOH/1.5 M NaCl. DNA was transferred by vacuum to Hybond-N nylon membrane (Amersham, Arlington Heights, IL, USA), using 20 × SSPE (3 M NaCl, 20 mM EDTA, and 200 mM NaH 2 PO 4 , pH 7.4). Blots were UV-cross-linked (150 mJ; Bio-Rad, Hercules, CA, USA), rinsed with ddH 2 O, and prehybridized overnight at 42°C in 50% formamide, 5 × SSPE, 0.5% sodium dodecyl sulfate (SDS), 5% dextran sulfate, 5 × Denhardt's reagent (0.2% bovine serum albumin, 0.2% polyvinylpyrrolidone, and 0.2% Ficoll), and 10 mg ml −1 herring sperm DNA. To synthesize probe for blots, we amplified in PCR reactions the 528-bp long allele of the 5HTT-LPR from PAC clone 6324 using as oligonucleotide primers, sense 5Ј-GGCGTTGCCGCTC TGAATGC-3Ј (RB 433); antisense 5ЈGAGGGACTGA GCTGGACAACCCAC-3Ј (RB 376). The PCR product was subcloned (pGEM-T-Easy, Promega), sequenced and then reexcised for [ 32 P]-labeling (Megaprime kit, Amersham) and then added directly to prehybridization buffer for an additional 12-24 h at 42°C. Blots were washed twice at room temperature with 2 × SSPE, 0.1% SDS buffer for 20 min, once at 42°C with 0.1 × SSPE, 0.1% SDS for 20 min, once at 65°C with 0.1 × SSPE, 0.1% SDS for 30 min, and once at room temperature with 2 × SSPE for 10 min. Blots were then exposed to either a PhosphorImager screen (Molecular Dynamics, Sunnyvale, CA, USA) or X-ray film (Amersham).
PCR analysis of genomic DNA for novel 5HTT sequences
The novel sequence identified in the 5HTT promoter from PAC clone 6324 was amplified in human genomic DNA with flanking oligonucleotide primers RB433 and RB597 (5Ј-CAAGACCAGCCTGGGCAACACAGCAA-GAC-3Ј) in 50-l reactions using the Expand Long Template PCR System protocol (Boehringer Mannheim, Indianapolis, IN, USA) and system buffer 3. Amplifications were performed on a Perkin Elmer thermocycler (2400 or 9700) with one cycle at 95°C/2 min followed by 30 cycles of 95°C/30 s, 61°C/30 s, 68°C/2 min, and a final 7-min extension at 68°C. PCR products were electrophoresed on a 2% agarose gel and visualized with ethidium bromide staining, sequenced after gel purification and subjected to Southern blot analysis as described for genomic Southerns, using the long 5HTT-LPR region as probe. The 5HTT-LPR genotypes were determined via agarose (2%) gel analysis of PCR amplifications using oligonucleotides RB433 and RB376 as primers, Taq polymerase (Promega) and cycle conditions as follows: 35 cycles of 94°C/5 min; 95°C/30 s; 61°C/30 s; 72°C/1 min.
The revised 5HTT promoter including the novel sequence has been deposited in GENBANK, accession number AF117826.
